Solid Biosciences Inc. (SLDB) Balance Sheet
As of 2026-06-30 (10-Q), Solid Biosciences Inc. (SLDB) reported total assets of $420.6M, total liabilities of $46.5M and shareholders' equity of $374.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $159.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SLDBSolid Biosciences Inc.Follow SLDB — free
—
Price chart with a free account
- Market cap
- 634.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 86.4 | 76.0 | 154.7 | 119.1 | 155.4 | 74.0 | 80.2 | 59.9 | 159.4 | |
| Short-term investments | 36.1 | 7.5 | — | 88.6 | 58.3 | 49.6 | 68.7 | 128.0 | 218.3 | |
| Current assets | 128.6 | 86.3 | 158.9 | 222.6 | 219.6 | 129.7 | 157.3 | 205.5 | 395.1 | |
| Total assets | 139.6 | 103.5 | 171.2 | 232.4 | 260.3 | 164.9 | 188.7 | 232.5 | 420.6 | |
| Current liabilities | 12.5 | 18.3 | 24.5 | 23.6 | 22.5 | 14.5 | 30.3 | 33.5 | 28.6 | |
| Total liabilities | 14.4 | 23.4 | 39.1 | 24.2 | 48.6 | 38.5 | 51.4 | 52.5 | 46.5 | |
| Shareholders' equity | 125.2 | 80.0 | 132.1 | 208.2 | 211.7 | 126.5 | 137.2 | 180.0 | 374.1 |
USD millions · SEC XBRL
Solid Biosciences Inc. — questions
- How much cash does Solid Biosciences Inc. have?
- $159.4M in cash and cash equivalents as of 2026-06-30.
- What are Solid Biosciences Inc.'s total assets?
- $420.6M as of 2026-06-30.
- What is Solid Biosciences Inc.'s shareholders' equity?
- $374.1M as of 2026-06-30.
Every figure on this page comes from Solid Biosciences Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.